$BHM

Bluerock Homes Trust (BHM) Announces Third Quarter Dividends on Series A Preferred Stock and Series B Preferred Stock

Bluerock Homes Trust, Inc. (NYSE American: BHM) said its board declared monthly cash dividends for Q3 2026 on its Series A and Series B redeemable preferred stocks. Series A pays $0.375 per share quarterly ($0.125 monthly) with payments Aug 5, Sep 4, and Oct 5, 2026. Series B pays $0.46875 per share quarterly ($0.15625 monthly) on the same dates.

Original reporting
Published Jul 13, 2026, 7:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 13, 2026, 7:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Bluerock Homes Trust (BHM) Announces Third Quarter Dividends on Series A Preferred Stock and Series B Preferred Stock — source image
Decision brief

The 30-second read

$BHMNeutralLow
01

Why it matters

Near-term income cash flows are specified with record and payment dates, and Series A includes an enhanced special dividend formula tied to SOFR, creating some rate-sensitivity for preferred holders.

02

Market read

This is a concrete, dated preferred dividend declaration with a floating-rate component for Series A, relevant mainly to preferred income pricing.

03

What to watch

Preferred dividend economics depend on the SOFR path for the enhanced special dividend period (26th to 25th), which could matter more for preferred holders than for common investors.

Relevance 5/10Novelty 6/10Timing: dividend record dates and August 5, 2026 first payment for Q3 2026

Background

The company announced monthly cash dividends for its Series A and Series B redeemable preferred stocks for Q3 2026, including a SOFR-linked enhanced special dividend for Series A.

Company-level read

Ticker impact

$BHMNeutralMedium confidence
Context

Bluerock Homes Trust declared Q3 2026 monthly cash dividends for its Series A and Series B preferred stock, with specific per-share amounts and record/pay dates.

Expected impact

Likely limited, mostly sentiment-neutral impact; any move would be concentrated in preferred shares rather than common.

Evidence & confidence

The release is a routine dividend declaration with detailed payment schedule and a SOFR-linked enhanced special dividend formula, but it does not introduce new guidance, financing, or balance-sheet changes.

Market effects

Reinforces that externally managed REIT preferred dividends may be structured with floating-rate enhanced components tied to SOFR.

No new regional demand or property-level information is provided.

No direct global linkage beyond general SOFR/rates sensitivity.

Counterpoint

Because the amounts are explicitly declared, the market may have already priced the income stream; common equity reaction may be muted.

Key entities

  • Bluerock Homes Trust, Inc.

    NYSE American-listed externally managed REIT that declared Q3 2026 preferred dividends.

  • Series A Redeemable Preferred Stock

    Declared monthly dividends for Q3 2026 plus SOFR-linked enhanced special dividends.

  • Series B Redeemable Preferred Stock

    Declared monthly dividends for Q3 2026 with specified per-share amounts and dates.

Related articles

$BHMMed

Bluerock Homes Trust, Inc. (BHM): Completion of Acquisition or Disposition of Assets

Bluerock Homes Trust, Inc. (BHM) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15( d ) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2026 BLUEROCK HOMES TRUST, INC. (Exact name of reg

$BHMLow

Bluerock Homes Trust, Inc. (BHM): Completion of Acquisition or Disposition of Assets

Bluerock Homes Trust, Inc. (BHM) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15( d ) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2026 BLUEROCK HOMES TRUST, INC. (Exact name of regi

$BHMLow

Bluerock Homes Trust, Inc. (BHM): Completion of Acquisition or Disposition of Assets

Bluerock Homes Trust, Inc. (BHM) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. false 0001903382 0001903382 2026-06-02 2026-06-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15( d ) of the Securities Exchange Act of 1934 Date of Rep

MedAI 8/10

Piraeus Bank S.A.: Ethniki Insurance Priced Its Inaugural €200mn Tier 2 and Restricted Tier 1 Perpetual Bonds

Piraeus Bank's subsidiary, Ethniki Insurance, priced its first €200mn subordinated bond issuance, comprising €100mn Tier 2 bonds at 5.25% and €100mn RT1 perpetual bonds at 6.875%. The offering was 3.0x oversubscribed, with strong international investor demand. The bonds will list on the Luxembourg Stock Exchange. Ethniki Insurance's Solvency II ratio stands at 190% post-issuance, according to the company.

$NVSMedAI 8/10

Novartis halted eight clinical trials of its experimental cell therapy rap-cel after three patients died from severe immune reactions

Novartis halted eight clinical trials of its experimental cell therapy rap-cel after three patients died from severe immune reactions. The pause affects trials for autoimmune and neurological disorders. Novartis is reviewing the deaths and sharing information with health authorities. Bristol Myers also paused studies of its rival CAR T-cell treatment zola-cel. Novartis shares rose 4% on Tuesday.